| Code | Description | Claims | Beneficiaries | Total Paid |
| 96361 |
Intravenous infusion, hydration; each additional hour |
56,926 |
46,857 |
$16.64M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
171,116 |
124,189 |
$12.35M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
104,261 |
95,574 |
$11.54M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
119,538 |
107,180 |
$10.05M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
83,656 |
76,987 |
$7.65M |
| J9271 |
Injection, pembrolizumab, 1 mg |
1,644 |
1,180 |
$6.99M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
32,722 |
31,020 |
$5.72M |
| J2350 |
Injection, ocrelizumab, 1 mg |
455 |
409 |
$5.02M |
| 77412 |
|
7,217 |
813 |
$3.33M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
27,245 |
20,702 |
$2.75M |
| 70450 |
Computed tomography, head or brain; without contrast material |
19,622 |
18,484 |
$2.66M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
11,156 |
7,934 |
$2.66M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
23,934 |
21,136 |
$2.57M |
| J2323 |
Injection, natalizumab, 1 mg |
1,615 |
1,437 |
$2.38M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
20,107 |
15,951 |
$2.23M |
| 77386 |
|
5,805 |
507 |
$2.07M |
| 59025 |
Fetal non-stress test |
11,165 |
8,203 |
$1.74M |
| 80053 |
Comprehensive metabolic panel |
339,690 |
292,141 |
$1.66M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
21,520 |
11,341 |
$1.60M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
62,496 |
48,457 |
$1.52M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
47,565 |
45,639 |
$1.46M |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
1,906 |
716 |
$1.44M |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
762 |
759 |
$1.39M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
15,311 |
14,820 |
$1.34M |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
98,097 |
94,466 |
$1.32M |
| 96415 |
|
6,814 |
4,801 |
$1.21M |
| 36415 |
Collection of venous blood by venipuncture |
439,423 |
381,538 |
$1.15M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
6,484 |
6,240 |
$1.14M |
| J9035 |
Injection, bevacizumab, 10 mg |
728 |
356 |
$1.06M |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
7,086 |
6,784 |
$1.04M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
21,388 |
17,695 |
$988K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
98,111 |
94,481 |
$940K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
385,163 |
324,022 |
$887K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
3,997 |
3,933 |
$860K |
| 84443 |
Thyroid stimulating hormone (TSH) |
88,835 |
86,210 |
$835K |
| 70496 |
|
4,680 |
4,552 |
$803K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
13,189 |
13,051 |
$799K |
| 76830 |
Ultrasound, transvaginal |
8,932 |
8,693 |
$769K |
| Q5115 |
Injection, rituximab-abbs, biosimilar, (truxima), 10 mg |
264 |
135 |
$762K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
734 |
733 |
$711K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
9,071 |
8,724 |
$689K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
157,039 |
147,633 |
$625K |
| 80061 |
Lipid panel |
92,747 |
91,535 |
$603K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
373 |
251 |
$597K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
10,489 |
10,199 |
$596K |
| 10060 |
|
3,366 |
3,221 |
$590K |
| 93971 |
|
6,148 |
5,893 |
$537K |
| 76801 |
|
10,382 |
9,353 |
$532K |
| 87070 |
|
97,382 |
94,080 |
$525K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
2,215 |
1,817 |
$507K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
968 |
945 |
$504K |
| 47562 |
|
222 |
215 |
$487K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
9,322 |
6,771 |
$472K |
| 58661 |
|
172 |
171 |
$457K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
88,059 |
86,763 |
$449K |
| 42830 |
|
250 |
246 |
$429K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
4,337 |
4,004 |
$403K |
| J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg |
446 |
169 |
$384K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
6,169 |
3,411 |
$379K |
| 12001 |
|
2,155 |
2,109 |
$376K |
| 95813 |
|
1,330 |
1,312 |
$368K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
1,566 |
1,267 |
$362K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
23,851 |
23,538 |
$354K |
| 64615 |
|
1,543 |
1,478 |
$354K |
| 96416 |
|
1,549 |
839 |
$353K |
| 70491 |
|
2,628 |
2,535 |
$347K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
65,681 |
56,742 |
$334K |
| 93970 |
|
3,232 |
3,107 |
$301K |
| 71046 |
Radiologic examination, chest; 2 views |
43,628 |
41,149 |
$293K |
| 82728 |
|
42,662 |
40,753 |
$286K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
40,957 |
40,211 |
$279K |
| 84484 |
|
65,561 |
48,606 |
$279K |
| 96367 |
|
5,190 |
3,710 |
$276K |
| 77336 |
|
4,861 |
2,123 |
$265K |
| 86780 |
|
29,108 |
28,661 |
$259K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,651 |
1,621 |
$257K |
| 80050 |
General health panel |
32,236 |
31,817 |
$250K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
841 |
830 |
$244K |
| 29581 |
|
1,872 |
619 |
$242K |
| J9312 |
Injection, rituximab, 10 mg |
105 |
67 |
$242K |
| G0378 |
Hospital observation service, per hour |
17,954 |
8,900 |
$241K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
3,489 |
3,452 |
$237K |
| 95800 |
|
1,162 |
1,148 |
$237K |
| 64405 |
|
1,186 |
1,130 |
$231K |
| 83880 |
|
27,392 |
25,040 |
$230K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
97,439 |
82,275 |
$230K |
| 36430 |
|
3,059 |
2,008 |
$230K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
49,988 |
49,220 |
$229K |
| 58571 |
|
76 |
74 |
$225K |
| J1950 |
Injection, leuprolide acetate (for depot suspension), per 3.75 mg |
379 |
335 |
$224K |
| J1453 |
Injection, fosaprepitant, 1 mg |
2,149 |
1,361 |
$218K |
| 87186 |
|
46,585 |
44,372 |
$216K |
| 76770 |
|
2,443 |
2,399 |
$214K |
| 87505 |
|
4,984 |
4,891 |
$202K |
| 87205 |
|
78,221 |
74,815 |
$202K |
| 84702 |
|
35,174 |
27,069 |
$200K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
18,375 |
17,700 |
$198K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
7,135 |
6,279 |
$196K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
638 |
618 |
$188K |
| 86803 |
|
37,827 |
37,184 |
$186K |
| 87808 |
|
44,576 |
43,333 |
$185K |
| 82607 |
|
27,028 |
26,015 |
$184K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
15,048 |
12,606 |
$181K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
1,153 |
1,118 |
$177K |
| 12002 |
|
1,079 |
1,064 |
$174K |
| J0897 |
Injection, denosumab, 1 mg |
1,624 |
1,392 |
$170K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,450 |
1,395 |
$168K |
| 84439 |
|
28,449 |
27,291 |
$168K |
| 73630 |
|
12,208 |
11,045 |
$167K |
| 83970 |
|
8,662 |
8,270 |
$166K |
| 64400 |
|
596 |
556 |
$165K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
3,763 |
3,463 |
$161K |
| 12011 |
|
999 |
976 |
$160K |
| 76536 |
|
1,929 |
1,912 |
$159K |
| 87529 |
|
8,888 |
7,546 |
$158K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,342 |
1,326 |
$157K |
| 49083 |
|
492 |
251 |
$152K |
| 76870 |
|
1,959 |
1,853 |
$152K |
| 83605 |
|
28,573 |
25,292 |
$151K |
| 86003 |
|
21,361 |
11,017 |
$150K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
17,318 |
16,895 |
$149K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
369 |
366 |
$148K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
11,292 |
11,180 |
$147K |
| 83550 |
|
37,472 |
35,732 |
$146K |
| 87481 |
|
17,720 |
16,883 |
$145K |
| 77334 |
|
1,483 |
1,110 |
$143K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
8,164 |
7,834 |
$142K |
| 82570 |
|
33,068 |
29,489 |
$141K |
| 86140 |
|
37,326 |
34,518 |
$140K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,598 |
1,574 |
$140K |
| 70498 |
|
4,932 |
4,802 |
$139K |
| 95806 |
|
267 |
265 |
$139K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
882 |
583 |
$134K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
5,811 |
5,660 |
$133K |
| 86480 |
|
7,373 |
7,275 |
$132K |
| J1756 |
Injection, iron sucrose, 1 mg |
7,187 |
3,231 |
$128K |
| 71250 |
|
2,679 |
2,628 |
$128K |
| 64450 |
|
489 |
451 |
$128K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
90,588 |
71,755 |
$126K |
| 87400 |
|
12,454 |
6,248 |
$126K |
| J0185 |
Injection, aprepitant, 1 mg |
1,599 |
941 |
$124K |
| 76937 |
|
3,573 |
3,203 |
$122K |
| 96523 |
|
3,432 |
2,670 |
$122K |
| 87040 |
|
18,698 |
10,450 |
$121K |
| 70487 |
|
747 |
730 |
$120K |
| 36561 |
|
111 |
107 |
$118K |
| 86235 |
|
12,921 |
7,322 |
$115K |
| 85027 |
|
30,579 |
28,166 |
$115K |
| 84403 |
|
9,776 |
9,491 |
$114K |
| 83540 |
|
39,386 |
37,599 |
$114K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
40,737 |
30,363 |
$112K |
| 70486 |
|
3,785 |
3,689 |
$111K |
| 58670 |
|
45 |
45 |
$108K |
| 73610 |
|
8,705 |
7,964 |
$100K |
| 29125 |
|
880 |
839 |
$100K |
| 77301 |
|
223 |
202 |
$96K |
| 82784 |
|
13,063 |
11,167 |
$96K |
| 82785 |
|
7,938 |
7,826 |
$96K |
| 80055 |
|
16,222 |
16,010 |
$95K |
| 77295 |
|
248 |
220 |
$92K |
| 72100 |
|
7,054 |
6,886 |
$91K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
2,816 |
2,363 |
$90K |
| 87149 |
|
15,594 |
15,058 |
$88K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
11,839 |
10,622 |
$87K |
| 90715 |
|
4,909 |
4,813 |
$87K |
| 74018 |
|
3,742 |
3,535 |
$86K |
| 83735 |
|
40,498 |
30,066 |
$84K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
397 |
382 |
$81K |
| 82746 |
|
18,229 |
17,459 |
$80K |
| 76820 |
|
2,945 |
1,509 |
$79K |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
154 |
132 |
$78K |
| 82247 |
|
13,011 |
9,822 |
$78K |
| 81229 |
|
324 |
321 |
$78K |
| 84146 |
|
6,726 |
6,560 |
$78K |
| 82670 |
|
5,392 |
5,222 |
$77K |
| 77300 |
|
1,481 |
1,277 |
$77K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
78,742 |
60,539 |
$77K |
| 87077 |
|
27,254 |
25,946 |
$75K |
| 73562 |
|
6,614 |
6,067 |
$75K |
| 87510 |
|
5,770 |
5,521 |
$75K |
| 85652 |
|
30,949 |
29,021 |
$74K |
| 87340 |
|
19,531 |
19,154 |
$74K |
| 86376 |
|
6,353 |
6,264 |
$72K |
| 81001 |
|
88,526 |
81,006 |
$72K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
785 |
778 |
$70K |
| 83001 |
|
7,633 |
7,521 |
$69K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
869 |
844 |
$69K |
| 72156 |
|
930 |
914 |
$68K |
| 36592 |
|
70,134 |
62,161 |
$68K |
| 72197 |
|
297 |
293 |
$68K |
| 83655 |
|
4,888 |
4,842 |
$68K |
| 85379 |
|
15,632 |
14,945 |
$67K |
| 87522 |
Neg quan hep c or qual rna |
3,904 |
3,801 |
$66K |
| 86706 |
|
16,468 |
16,153 |
$65K |
| 73030 |
|
7,564 |
7,009 |
$65K |
| 77290 |
|
230 |
218 |
$65K |
| 86665 |
|
6,513 |
3,632 |
$64K |
| 86039 |
|
11,476 |
11,211 |
$63K |
| 80076 |
|
13,584 |
10,968 |
$62K |
| 86481 |
|
3,356 |
3,305 |
$61K |
| 52356 |
|
44 |
41 |
$61K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
5,439 |
5,322 |
$60K |
| 72193 |
|
310 |
301 |
$60K |
| 86704 |
|
12,710 |
12,465 |
$60K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,166 |
1,155 |
$58K |
| 82950 |
|
16,842 |
16,683 |
$58K |
| 82105 |
|
5,532 |
5,390 |
$57K |
| 58662 |
|
27 |
27 |
$56K |
| 87660 |
|
5,770 |
5,521 |
$56K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
2,758 |
2,496 |
$56K |
| 73130 |
|
6,953 |
6,371 |
$56K |
| 84703 |
|
49,989 |
45,735 |
$54K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
657 |
435 |
$53K |
| 95811 |
|
156 |
155 |
$53K |
| 72141 |
|
573 |
562 |
$53K |
| 74175 |
|
319 |
312 |
$51K |
| 86695 |
|
5,731 |
5,640 |
$51K |
| 74174 |
|
296 |
285 |
$51K |
| 97803 |
|
1,294 |
1,126 |
$51K |
| 73110 |
|
5,251 |
4,777 |
$50K |
| 83013 |
|
2,579 |
2,550 |
$50K |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
115 |
51 |
$49K |
| 83690 |
|
50,391 |
45,404 |
$48K |
| 44970 |
|
13 |
12 |
$47K |
| 76813 |
|
1,246 |
1,212 |
$47K |
| Q3014 |
Telehealth originating site facility fee |
2,201 |
2,075 |
$46K |
| 80074 |
|
5,645 |
5,550 |
$46K |
| 86696 |
|
6,770 |
6,672 |
$46K |
| 83002 |
|
4,995 |
4,921 |
$46K |
| 84156 |
|
16,489 |
14,627 |
$45K |
| 81003 |
|
65,982 |
61,920 |
$45K |
| 73502 |
|
4,505 |
4,287 |
$44K |
| J9310 |
Injection, rituximab, 100 mg |
19 |
12 |
$44K |
| 87081 |
|
15,239 |
15,053 |
$44K |
| 80143 |
|
12,410 |
11,135 |
$44K |
| 83993 |
|
3,370 |
3,328 |
$44K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
18,848 |
18,094 |
$43K |
| 86256 |
|
6,267 |
5,718 |
$43K |
| 82677 |
|
2,070 |
2,041 |
$43K |
| 82043 |
|
18,025 |
17,703 |
$43K |
| 95913 |
|
296 |
290 |
$42K |
| 72131 |
|
1,559 |
1,522 |
$42K |
| 86800 |
|
3,604 |
3,536 |
$42K |
| 87631 |
|
1,508 |
1,482 |
$41K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
3,338 |
2,661 |
$41K |
| 97597 |
|
811 |
547 |
$41K |
| 86364 |
|
5,419 |
5,349 |
$41K |
| 84153 |
|
6,354 |
6,100 |
$40K |
| 83520 |
|
5,929 |
4,842 |
$39K |
| J2357 |
Injection, omalizumab, 5 mg |
80 |
61 |
$39K |
| 87480 |
|
5,770 |
5,521 |
$39K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
9,689 |
9,350 |
$39K |
| 67311 |
|
13 |
13 |
$39K |
| 71045 |
Radiologic examination, chest; single view |
32,816 |
30,174 |
$38K |
| 82248 |
|
9,073 |
6,728 |
$37K |
| 0001A |
|
1,179 |
1,172 |
$37K |
| 73560 |
|
4,432 |
4,023 |
$37K |
| 36591 |
|
8,350 |
5,010 |
$36K |
| 84481 |
|
6,630 |
6,469 |
$36K |
| E0604 |
Breast pump, hospital grade, electric (ac and / or dc), any type |
1,154 |
528 |
$36K |
| 88307 |
|
2,064 |
1,834 |
$35K |
| 84550 |
|
23,540 |
19,200 |
$35K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
609 |
604 |
$35K |
| 83516 |
|
5,617 |
3,628 |
$35K |
| 82330 |
|
9,325 |
8,696 |
$34K |
| 82533 |
|
4,513 |
3,610 |
$34K |
| 0002A |
|
857 |
856 |
$34K |
| 84145 |
|
3,502 |
3,320 |
$33K |
| 80164 |
|
3,832 |
3,592 |
$33K |
| 77338 |
|
292 |
240 |
$32K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
898 |
435 |
$32K |
| 96368 |
|
3,008 |
1,921 |
$32K |
| J1447 |
Injection, tbo-filgrastim, 1 microgram |
188 |
60 |
$32K |
| 84270 |
|
3,226 |
3,169 |
$32K |
| 73140 |
|
2,755 |
2,640 |
$31K |
| 97802 |
|
487 |
478 |
$31K |
| 10061 |
|
213 |
204 |
$31K |
| 86787 |
|
5,763 |
4,539 |
$31K |
| 84144 |
|
2,864 |
2,725 |
$30K |
| 72040 |
|
1,845 |
1,816 |
$30K |
| 72158 |
|
222 |
218 |
$29K |
| 85610 |
|
50,407 |
36,221 |
$28K |
| 96417 |
|
5,458 |
3,433 |
$28K |
| 74183 |
|
146 |
146 |
$28K |
| 64721 |
|
52 |
50 |
$28K |
| 83883 |
|
3,395 |
1,840 |
$28K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
730 |
459 |
$27K |
| 86762 |
|
4,086 |
3,558 |
$27K |
| 82951 |
|
3,304 |
3,277 |
$27K |
| 73221 |
|
186 |
183 |
$27K |
| 83615 |
|
20,264 |
14,481 |
$27K |
| 83525 |
|
2,928 |
2,831 |
$26K |
| 82550 |
|
14,400 |
13,032 |
$26K |
| 99152 |
|
4,810 |
4,591 |
$26K |
| 73701 |
|
161 |
156 |
$26K |
| J9202 |
Goserelin acetate implant, per 3.6 mg |
110 |
101 |
$26K |
| 86160 |
|
6,669 |
4,654 |
$25K |
| 95886 |
|
1,218 |
1,201 |
$25K |
| J3490 |
Unclassified drugs |
1,099 |
972 |
$25K |
| 99153 |
Mod sedat endo service >5yrs |
4,065 |
3,870 |
$25K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
611 |
590 |
$24K |
| 97162 |
|
736 |
714 |
$24K |
| 86431 |
|
5,718 |
5,661 |
$24K |
| J2704 |
Injection, propofol, 10 mg |
24,777 |
23,202 |
$24K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
386 |
369 |
$24K |
| 58558 |
|
25 |
24 |
$24K |
| 84100 |
|
12,970 |
9,676 |
$24K |
| 80178 |
|
2,845 |
2,628 |
$24K |
| 87430 |
|
8,687 |
8,449 |
$24K |
| 85014 |
|
7,129 |
6,324 |
$23K |
| 73080 |
|
1,911 |
1,819 |
$23K |
| 84165 |
|
6,020 |
5,499 |
$23K |
| 87209 |
|
3,216 |
3,147 |
$23K |
| 97161 |
|
690 |
666 |
$22K |
| 86334 |
|
3,809 |
3,492 |
$22K |
| 80179 |
|
12,360 |
11,115 |
$22K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
56,829 |
52,836 |
$22K |
| 73590 |
|
3,693 |
3,391 |
$22K |
| 87493 |
|
2,729 |
2,669 |
$22K |
| 80177 |
|
2,438 |
2,321 |
$22K |
| 80069 |
|
3,320 |
3,071 |
$22K |
| J9201 |
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg |
136 |
38 |
$21K |
| 86225 |
|
4,497 |
4,421 |
$21K |
| D2393 |
Resin-based composite - three surfaces, posterior, primary or permanent |
12 |
12 |
$20K |
| 87338 |
|
2,955 |
2,932 |
$20K |
| 86200 |
|
3,888 |
3,853 |
$20K |
| 86850 |
|
10,981 |
9,791 |
$20K |
| 82627 |
|
2,039 |
2,004 |
$19K |
| D2930 |
Prefabricated stainless steel crown - primary tooth |
22 |
22 |
$19K |
| 80197 |
|
2,046 |
1,665 |
$19K |
| 88342 |
|
2,270 |
2,050 |
$19K |
| 76642 |
|
205 |
184 |
$19K |
| 73700 |
|
264 |
259 |
$19K |
| 64483 |
|
48 |
48 |
$18K |
| 84480 |
|
2,689 |
2,607 |
$18K |
| 82378 |
|
4,793 |
3,677 |
$18K |
| 86304 |
|
2,057 |
1,800 |
$18K |
| 83020 |
|
2,162 |
2,046 |
$18K |
| 86812 |
|
1,461 |
1,443 |
$18K |
| 86147 |
|
2,064 |
1,372 |
$18K |
| 84410 |
|
998 |
974 |
$18K |
| A4649 |
Surgical supply; miscellaneous |
7,391 |
6,672 |
$18K |
| 86308 |
|
3,967 |
3,917 |
$17K |
| 71101 |
|
2,578 |
2,495 |
$17K |
| 73090 |
|
2,265 |
2,103 |
$17K |
| 86708 |
|
2,848 |
2,813 |
$17K |
| 73120 |
|
655 |
492 |
$17K |
| J3489 |
Injection, zoledronic acid, 1 mg |
1,152 |
1,080 |
$17K |
| 71271 |
|
189 |
182 |
$17K |
| J9206 |
Injection, irinotecan, 20 mg |
170 |
52 |
$17K |
| 69209 |
|
180 |
175 |
$16K |
| 72157 |
|
240 |
236 |
$16K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
1,065 |
1,034 |
$16K |
| 86923 |
|
2,108 |
1,368 |
$16K |
| 87641 |
|
1,019 |
983 |
$15K |
| 72072 |
|
825 |
810 |
$15K |
| 86900 |
|
11,963 |
10,701 |
$15K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
524 |
165 |
$15K |
| 86008 |
|
2,114 |
1,943 |
$15K |
| 82565 |
|
7,703 |
7,307 |
$15K |
| 81025 |
|
23,083 |
22,043 |
$14K |
| 86301 |
|
1,534 |
1,109 |
$14K |
| 84134 |
|
1,817 |
1,123 |
$14K |
| Q5102 |
Injection, infliximab, biosimilar, 10 mg |
16 |
13 |
$14K |
| 87177 |
|
3,218 |
3,149 |
$14K |
| 73552 |
|
1,622 |
1,512 |
$14K |
| 85730 |
|
13,816 |
12,992 |
$14K |
| J9070 |
Cyclophosphamide, 100 mg |
176 |
88 |
$14K |
| 80175 |
|
1,675 |
1,618 |
$14K |
| 86677 |
|
1,225 |
1,216 |
$14K |
| 86870 |
|
1,383 |
1,010 |
$13K |
| 75574 |
|
70 |
69 |
$13K |
| 84445 |
|
623 |
613 |
$13K |
| 88304 |
|
3,323 |
3,100 |
$13K |
| 84432 |
|
919 |
796 |
$13K |
| 85018 |
|
6,221 |
5,449 |
$13K |
| 95812 |
|
45 |
45 |
$13K |
| 83014 |
|
2,576 |
2,547 |
$13K |
| 88185 |
|
516 |
447 |
$13K |
| 87634 |
|
556 |
548 |
$13K |
| 82232 |
|
1,269 |
1,052 |
$13K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
29,802 |
24,560 |
$13K |
| 84425 |
|
2,294 |
2,266 |
$12K |
| 78306 |
|
66 |
63 |
$12K |
| 99195 |
|
369 |
320 |
$12K |
| 82274 |
|
2,767 |
2,746 |
$12K |
| 87517 |
|
808 |
694 |
$12K |
| 83721 |
|
2,358 |
2,337 |
$12K |
| 85651 |
|
4,040 |
3,762 |
$12K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
39 |
39 |
$12K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,722 |
6,477 |
$12K |
| 82952 |
|
3,230 |
3,062 |
$12K |
| 70544 |
|
149 |
144 |
$12K |
| 82977 |
|
6,869 |
6,481 |
$12K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
104 |
66 |
$11K |
| 73660 |
|
949 |
913 |
$11K |
| 86146 |
|
1,417 |
1,055 |
$11K |
| 82947 |
|
7,739 |
7,495 |
$11K |
| 96376 |
|
20,597 |
15,185 |
$11K |
| 84305 |
|
870 |
861 |
$11K |
| 83498 |
|
907 |
890 |
$11K |
| 97166 |
|
341 |
331 |
$11K |
| 84450 |
|
7,797 |
7,507 |
$11K |
| 84163 |
|
977 |
951 |
$11K |
| 86300 |
|
1,494 |
1,184 |
$11K |
| 86756 |
|
3,082 |
2,956 |
$10K |
| 0012A |
|
270 |
269 |
$10K |
| 20610 |
|
54 |
53 |
$10K |
| 82150 |
|
6,415 |
6,188 |
$10K |
| 87184 |
|
3,789 |
3,725 |
$10K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
49,205 |
44,427 |
$10K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
439 |
285 |
$10K |
| 77001 |
|
302 |
293 |
$10K |
| 29515 |
|
175 |
165 |
$10K |
| 86901 |
|
13,027 |
11,618 |
$9K |
| 86336 |
|
2,109 |
2,079 |
$9K |
| 86694 |
|
745 |
660 |
$9K |
| 84460 |
|
8,093 |
7,799 |
$9K |
| 87046 |
|
1,688 |
1,659 |
$9K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
72,758 |
58,725 |
$9K |
| 0011A |
|
328 |
325 |
$9K |
| 87328 |
|
1,783 |
1,761 |
$9K |
| 36416 |
|
31,618 |
26,609 |
$9K |
| 87210 |
|
1,976 |
1,881 |
$9K |
| 82542 |
|
1,019 |
996 |
$9K |
| 72128 |
|
566 |
555 |
$8K |
| 72170 |
|
1,964 |
1,879 |
$8K |
| 82040 |
|
6,417 |
6,192 |
$8K |
| 90686 |
|
713 |
696 |
$7K |
| 74178 |
|
51 |
50 |
$7K |
| 80203 |
|
933 |
900 |
$7K |
| 87536 |
|
117 |
110 |
$7K |
| 81015 |
|
2,885 |
2,795 |
$7K |
| 84166 |
|
974 |
892 |
$7K |
| 88341 |
|
1,268 |
1,068 |
$7K |
| 85045 |
|
3,909 |
3,483 |
$7K |
| 82465 |
|
3,119 |
3,035 |
$7K |
| 36590 |
|
12 |
12 |
$7K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
27 |
27 |
$7K |
| 97165 |
|
182 |
181 |
$7K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
257 |
102 |
$7K |
| 72070 |
|
1,012 |
989 |
$7K |
| 96402 |
|
2,301 |
2,050 |
$7K |
| 81050 |
|
3,005 |
2,321 |
$6K |
| 43235 |
|
12 |
12 |
$6K |
| 81241 |
|
278 |
274 |
$6K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
222 |
218 |
$6K |
| 77387 |
|
2,375 |
281 |
$6K |
| 82239 |
|
686 |
601 |
$6K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
2,342 |
2,280 |
$6K |
| 93798 |
|
1,042 |
331 |
$6K |
| 93017 |
|
62 |
62 |
$6K |
| 95911 |
|
39 |
38 |
$6K |
| 87593 |
|
72 |
47 |
$6K |
| 82962 |
|
16,893 |
9,692 |
$6K |
| 62323 |
|
12 |
12 |
$6K |
| 87625 |
|
734 |
726 |
$6K |
| 84155 |
|
6,118 |
5,854 |
$6K |
| 83521 |
|
1,743 |
1,438 |
$6K |
| 84681 |
|
658 |
648 |
$6K |
| 86880 |
|
2,086 |
1,873 |
$6K |
| 84478 |
|
1,915 |
1,515 |
$6K |
| 82652 |
|
442 |
441 |
$6K |
| 82103 |
|
688 |
677 |
$6K |
| 36569 |
|
14 |
14 |
$6K |
| 82390 |
|
865 |
852 |
$6K |
| 20553 |
|
67 |
57 |
$6K |
| 85613 |
|
1,116 |
1,011 |
$5K |
| 87329 |
|
1,755 |
1,735 |
$5K |
| 96040 |
|
680 |
655 |
$5K |
| 88112 |
|
667 |
630 |
$5K |
| 86920 |
|
914 |
486 |
$5K |
| 82140 |
|
1,271 |
1,179 |
$5K |
| 82310 |
|
2,796 |
2,661 |
$5K |
| 87632 |
|
48 |
48 |
$5K |
| 16020 |
|
41 |
38 |
$5K |
| 77470 |
|
29 |
26 |
$5K |
| 86735 |
|
1,301 |
1,220 |
$5K |
| 87420 |
|
342 |
335 |
$5K |
| 82024 |
|
648 |
501 |
$5K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
18,363 |
14,509 |
$5K |
| C1769 |
Guide wire |
5,001 |
4,580 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
535 |
507 |
$5K |
| 85240 |
|
1,087 |
1,045 |
$5K |
| 83010 |
|
787 |
655 |
$5K |
| 73070 |
|
1,451 |
1,345 |
$5K |
| 86765 |
|
1,240 |
1,209 |
$5K |
| 83090 |
|
355 |
347 |
$5K |
| 77280 |
|
29 |
24 |
$5K |
| 51798 |
|
1,274 |
1,097 |
$4K |
| 73060 |
|
872 |
814 |
$4K |
| 86592 |
|
1,538 |
1,509 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
22,712 |
18,583 |
$4K |
| 90674 |
|
369 |
357 |
$4K |
| 77332 |
|
78 |
67 |
$4K |
| 96401 |
|
1,438 |
671 |
$4K |
| 0031A |
|
111 |
109 |
$4K |
| 86769 |
|
776 |
768 |
$4K |
| 82731 |
|
192 |
186 |
$4K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
828 |
817 |
$4K |
| D7140 |
Extraction, erupted tooth or exposed root |
12 |
12 |
$4K |
| 82525 |
|
386 |
379 |
$4K |
| 74022 |
|
399 |
388 |
$4K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
1,891 |
1,674 |
$4K |
| 80159 |
|
506 |
383 |
$4K |
| 80183 |
|
376 |
366 |
$4K |
| 73564 |
|
174 |
141 |
$4K |
| 94010 |
|
211 |
204 |
$4K |
| 59020 |
|
40 |
36 |
$4K |
| 84630 |
|
433 |
425 |
$4K |
| 99215 |
Prolong outpt/office vis |
61 |
57 |
$4K |
| 72050 |
|
131 |
130 |
$3K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
34,834 |
14,924 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
37,423 |
29,594 |
$3K |
| 96411 |
|
3,170 |
1,988 |
$3K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
4,369 |
1,448 |
$3K |
| 82668 |
|
561 |
545 |
$3K |
| 10005 |
|
13 |
13 |
$3K |
| 87902 |
|
161 |
159 |
$3K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
12 |
12 |
$3K |
| 88173 |
|
250 |
205 |
$3K |
| 88360 |
|
202 |
174 |
$3K |
| 86360 |
|
234 |
227 |
$3K |
| 81240 |
|
256 |
252 |
$3K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,166 |
1,155 |
$3K |
| 77080 |
|
60 |
58 |
$3K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
4,663 |
3,806 |
$3K |
| 76942 |
|
41 |
38 |
$3K |
| 88184 |
|
483 |
449 |
$3K |
| 80051 |
|
4,075 |
3,894 |
$3K |
| 83021 |
|
673 |
590 |
$3K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
15,471 |
13,902 |
$3K |
| 85007 |
|
2,751 |
1,946 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
26,672 |
24,160 |
$3K |
| 82077 |
|
14,929 |
12,562 |
$3K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
173 |
172 |
$3K |
| 77066 |
Tomosynthesis, mammo |
87 |
87 |
$3K |
| 81596 |
|
98 |
96 |
$3K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
8,312 |
6,859 |
$3K |
| 81243 |
|
72 |
72 |
$3K |
| 82270 |
|
2,093 |
2,019 |
$2K |
| C1760 |
Closure device, vascular (implantable/insertable) |
1,652 |
1,609 |
$2K |
| 82010 |
|
3,780 |
3,351 |
$2K |
| 10160 |
|
25 |
24 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
30 |
30 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
22,294 |
17,139 |
$2K |
| 86036 |
|
473 |
465 |
$2K |
| 86141 |
|
411 |
401 |
$2K |
| J2060 |
Injection, lorazepam, 2 mg |
7,362 |
6,269 |
$2K |
| 84520 |
|
4,632 |
4,381 |
$2K |
| 82553 |
|
247 |
231 |
$2K |
| J9267 |
Injection, paclitaxel, 1 mg |
2,668 |
1,018 |
$2K |
| 82681 |
|
223 |
220 |
$2K |
| 86778 |
|
206 |
199 |
$2K |
| 86341 |
|
260 |
257 |
$2K |
| 86593 |
|
844 |
826 |
$2K |
| 87075 |
|
690 |
625 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
15 |
15 |
$2K |
| 84466 |
|
396 |
388 |
$2K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
15,074 |
12,708 |
$2K |
| J8540 |
Dexamethasone, oral, 0.25 mg |
5,268 |
4,082 |
$2K |
| 84132 |
|
1,484 |
1,402 |
$2K |
| 91065 |
|
86 |
86 |
$2K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
1,070 |
1,020 |
$2K |
| 92567 |
|
212 |
208 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
28,015 |
24,121 |
$2K |
| 92610 |
|
54 |
52 |
$1K |
| J9190 |
Injection, fluorouracil, 500 mg |
6,226 |
1,604 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
16,960 |
16,125 |
$1K |
| 80299 |
|
263 |
253 |
$1K |
| 84436 |
|
189 |
188 |
$1K |
| 87045 |
|
241 |
234 |
$1K |
| 87101 |
|
242 |
240 |
$1K |
| 87102 |
|
535 |
502 |
$1K |
| 84075 |
|
4,282 |
4,096 |
$1K |
| 70549 |
|
15 |
14 |
$1K |
| 86645 |
|
126 |
124 |
$1K |
| 83718 |
|
115 |
114 |
$1K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
34 |
28 |
$1K |
| P9040 |
Red blood cells, leukocytes reduced, irradiated, each unit |
41 |
25 |
$1K |
| 86777 |
|
208 |
199 |
$1K |
| 73000 |
|
109 |
103 |
$1K |
| 99151 |
|
15 |
13 |
$1K |
| 85048 |
|
179 |
174 |
$1K |
| 80185 |
|
120 |
108 |
$1K |
| 74019 |
|
26 |
24 |
$1K |
| 41800 |
|
14 |
14 |
$1K |
| C1781 |
Mesh (implantable) |
260 |
253 |
$1K |
| 77333 |
|
14 |
13 |
$1K |
| 76857 |
|
29 |
29 |
$1K |
| D3220 |
Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction |
17 |
17 |
$1K |
| 93797 |
|
307 |
79 |
$1K |
| 86644 |
|
116 |
113 |
$1K |
| 85390 |
|
490 |
478 |
$988.99 |
| 84590 |
|
162 |
161 |
$987.33 |
| 89055 |
|
602 |
594 |
$934.46 |
| 87427 |
|
237 |
233 |
$921.93 |
| 77002 |
|
12 |
12 |
$892.80 |
| 70360 |
|
92 |
87 |
$881.19 |
| 87449 |
|
153 |
150 |
$881.00 |
| 85246 |
|
170 |
167 |
$869.53 |
| 82805 |
|
1,551 |
1,402 |
$869.09 |
| 72220 |
|
101 |
96 |
$852.62 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
4,633 |
2,540 |
$842.70 |
| 85245 |
|
124 |
118 |
$833.12 |
| 86359 |
|
207 |
201 |
$825.37 |
| 93923 |
|
12 |
12 |
$804.78 |
| J1940 |
Injection, furosemide, up to 20 mg |
2,958 |
2,184 |
$803.83 |
| 96409 |
|
72 |
36 |
$772.20 |
| C1776 |
Joint device (implantable) |
54 |
51 |
$756.43 |
| 87220 |
|
239 |
238 |
$749.41 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,624 |
6,388 |
$745.90 |
| 51702 |
|
191 |
163 |
$716.48 |
| G0498 |
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion |
1,172 |
659 |
$710.35 |
| 85306 |
|
159 |
151 |
$700.02 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
3,623 |
3,511 |
$694.49 |
| 82365 |
|
164 |
149 |
$681.66 |
| M0220 |
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring |
73 |
72 |
$666.62 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
3,292 |
3,049 |
$656.90 |
| 84235 |
|
29 |
28 |
$650.38 |
| 84181 |
|
94 |
90 |
$630.74 |
| 84402 |
|
50 |
50 |
$629.50 |
| J9045 |
Injection, carboplatin, 50 mg |
1,796 |
1,089 |
$606.14 |
| 90714 |
|
32 |
31 |
$587.83 |
| 80156 |
|
59 |
57 |
$584.30 |
| G2215 |
Take-home supply of nasal naloxone; 2-pack of 4mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure |
56 |
51 |
$576.47 |
| 92582 |
|
13 |
13 |
$568.10 |
| 0225U |
|
989 |
979 |
$550.26 |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
50 |
38 |
$548.02 |
| 92524 |
|
13 |
12 |
$541.09 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
1,417 |
1,358 |
$534.37 |
| 77065 |
Tomosynthesis, mammo |
17 |
17 |
$511.98 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
6,686 |
6,038 |
$509.24 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
170 |
161 |
$502.23 |
| 76802 |
|
14 |
12 |
$490.37 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
9,487 |
2,949 |
$489.69 |
| J1630 |
Injection, haloperidol, up to 5 mg |
3,496 |
3,029 |
$477.40 |
| J3480 |
Injection, potassium chloride, per 2 meq |
3,972 |
2,493 |
$469.27 |
| 85303 |
|
138 |
132 |
$469.06 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
1,168 |
1,151 |
$458.92 |
| 95250 |
|
13 |
13 |
$453.55 |
| 76812 |
|
13 |
12 |
$446.60 |
| 84446 |
|
64 |
63 |
$435.64 |
| 85384 |
|
440 |
395 |
$422.72 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
6,619 |
3,722 |
$421.06 |
| C1729 |
Catheter, drainage |
2,490 |
1,497 |
$420.94 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
253 |
226 |
$417.32 |
| 86618 |
|
55 |
54 |
$409.81 |
| 89051 |
|
918 |
743 |
$401.14 |
| 73600 |
|
16 |
12 |
$370.90 |
| J3360 |
Injection, diazepam, up to 5 mg |
1,229 |
1,162 |
$370.50 |
| 88300 |
|
28 |
28 |
$362.63 |
| 82626 |
|
29 |
29 |
$358.03 |
| 74220 |
|
12 |
12 |
$356.15 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
599 |
447 |
$349.90 |
| C9113 |
Injection, pantoprazole sodium, per vial |
902 |
579 |
$340.78 |
| 82164 |
|
46 |
41 |
$330.64 |
| J1815 |
Injection, insulin, per 5 units |
6,261 |
3,674 |
$328.05 |
| 92555 |
|
24 |
24 |
$326.92 |
| 36593 |
|
12 |
12 |
$324.77 |
| 86352 |
|
12 |
12 |
$324.27 |
| 73521 |
|
12 |
12 |
$320.84 |
| 81270 |
|
15 |
15 |
$319.80 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,879 |
1,388 |
$314.51 |
| J1644 |
Injection, heparin sodium, per 1000 units |
9,819 |
5,505 |
$306.92 |
| 82672 |
|
25 |
24 |
$303.65 |
| 97760 |
|
18 |
12 |
$299.70 |
| J1790 |
Injection, droperidol, up to 5 mg |
1,587 |
1,431 |
$282.62 |
| 76380 |
|
12 |
12 |
$280.04 |
| 80202 |
|
27 |
12 |
$271.42 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
382 |
367 |
$267.80 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
26 |
26 |
$266.31 |
| 84112 |
|
183 |
171 |
$257.71 |
| 85300 |
|
100 |
99 |
$251.37 |
| 89125 |
|
78 |
77 |
$250.85 |
| 0003A |
|
12 |
12 |
$243.20 |
| 84207 |
|
49 |
48 |
$235.69 |
| 72192 |
|
12 |
12 |
$235.01 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
126 |
109 |
$234.71 |
| 88142 |
|
14 |
14 |
$231.78 |
| 80305 |
|
1,614 |
1,539 |
$218.64 |
| 84244 |
|
24 |
24 |
$214.70 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
359 |
220 |
$205.25 |
| 87116 |
|
15 |
12 |
$195.14 |
| 87140 |
|
15 |
14 |
$192.30 |
| 83519 |
|
36 |
25 |
$188.78 |
| 80162 |
|
17 |
14 |
$184.48 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
749 |
535 |
$179.12 |
| 81256 |
|
15 |
15 |
$177.96 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
4,323 |
3,068 |
$171.80 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,297 |
2,235 |
$164.28 |
| C9399 |
Unclassified drugs or biologicals |
286 |
183 |
$162.80 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
2,014 |
1,885 |
$162.71 |
| 82803 |
|
3,492 |
3,011 |
$160.86 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
920 |
832 |
$132.64 |
| 85660 |
|
78 |
54 |
$124.50 |
| 90656 |
|
13 |
12 |
$117.80 |
| 82085 |
|
37 |
36 |
$111.82 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
588 |
345 |
$109.30 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
128 |
122 |
$104.52 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
2,715 |
2,409 |
$101.43 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
65 |
62 |
$100.14 |
| 86335 |
|
27 |
26 |
$99.70 |
| 87341 |
|
24 |
24 |
$88.89 |
| 92587 |
|
13 |
12 |
$82.56 |
| C9463 |
Injection, aprepitant, 1 mg |
194 |
103 |
$79.01 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
601 |
592 |
$71.11 |
| 85347 |
|
560 |
375 |
$69.83 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
6,101 |
5,337 |
$69.45 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
538 |
523 |
$67.61 |
| 87110 |
|
15 |
14 |
$66.20 |
| J3411 |
Injection, thiamine hcl, 100 mg |
805 |
605 |
$62.03 |
| 85307 |
|
13 |
12 |
$61.26 |
| 99173 |
|
31 |
31 |
$58.00 |
| 86922 |
|
23 |
12 |
$57.30 |
| C1758 |
Catheter, ureteral |
547 |
487 |
$53.05 |
| 87425 |
|
13 |
13 |
$52.43 |
| 88302 |
|
110 |
102 |
$52.39 |
| C2625 |
Stent, non-coronary, temporary, with delivery system |
220 |
211 |
$51.63 |
| 87015 |
|
15 |
12 |
$41.81 |
| 84300 |
|
12 |
12 |
$40.11 |
| 87206 |
|
16 |
13 |
$35.53 |
| 90662 |
|
114 |
109 |
$31.52 |
| G0472 |
Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
620 |
618 |
$30.47 |
| J1956 |
Injection, levofloxacin, 250 mg |
757 |
696 |
$28.32 |
| A4314 |
Insertion tray with drainage bag with indwelling catheter, foley type, two-way latex with coating (teflon, silicone, silicone elastomer or hydrophilic, etc.) |
1,715 |
1,628 |
$28.10 |
| 86162 |
|
14 |
13 |
$26.88 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
1,291 |
1,156 |
$22.91 |
| 87088 |
|
422 |
402 |
$13.36 |
| 83930 |
|
14 |
12 |
$13.29 |
| 90694 |
|
26 |
25 |
$13.08 |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
14 |
12 |
$11.61 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
2,148 |
2,061 |
$10.02 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
302 |
281 |
$6.44 |
| J0456 |
Injection, azithromycin, 500 mg |
303 |
265 |
$5.12 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
529 |
495 |
$4.63 |
| J1836 |
Injection, metronidazole, 10 mg |
533 |
351 |
$3.56 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
910 |
883 |
$3.16 |
| 87905 |
|
252 |
244 |
$2.28 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
119 |
88 |
$2.20 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
20 |
12 |
$1.88 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
1,024 |
846 |
$1.01 |
| A4351 |
Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, or silicone elastomer, etc.), each |
706 |
694 |
$0.82 |
| S2900 |
Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) |
120 |
116 |
$0.76 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
531 |
500 |
$0.46 |
| 84157 |
|
12 |
12 |
$0.44 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
234 |
223 |
$0.29 |
| Q0220 |
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg |
83 |
74 |
$0.28 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
766 |
550 |
$0.00 |
| J9060 |
Injection, cisplatin, powder or solution, 10 mg |
176 |
76 |
$0.00 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
20 |
15 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
25,496 |
21,171 |
$0.00 |
| J2720 |
Injection, protamine sulfate, per 10 mg |
37 |
37 |
$0.00 |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
51 |
46 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
124 |
95 |
$0.00 |
| A4358 |
Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, each |
67 |
54 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
437 |
336 |
$0.00 |
| D1120 |
Prophylaxis - child |
34 |
34 |
$0.00 |
| 77062 |
|
85 |
85 |
$0.00 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
168 |
166 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
125 |
123 |
$0.00 |
| J0737 |
Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg |
134 |
125 |
$0.00 |
| C1788 |
Port, indwelling (implantable) |
151 |
142 |
$0.00 |
| J3473 |
Injection, hyaluronidase, recombinant, 1 usp unit |
12 |
12 |
$0.00 |
| 91300 |
|
1,837 |
1,693 |
$0.00 |
| A9537 |
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries |
12 |
12 |
$0.00 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
12 |
12 |
$0.00 |
| J3371 |
Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg |
41 |
23 |
$0.00 |
| D0220 |
Intraoral - periapical first radiographic image |
18 |
18 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
169 |
156 |
$0.00 |
| A4338 |
Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each |
230 |
205 |
$0.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
122 |
113 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
693 |
658 |
$0.00 |
| J0173 |
Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg |
239 |
227 |
$0.00 |
| J2305 |
Injection, nitroglycerin, 5 mg |
25 |
24 |
$0.00 |
| J9181 |
Injection, etoposide, 10 mg |
56 |
12 |
$0.00 |
| 91301 |
|
578 |
558 |
$0.00 |
| D0230 |
Intraoral - periapical each additional radiographic image |
18 |
18 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
13 |
13 |
$0.00 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
20 |
16 |
$0.00 |
| 96521 |
|
65 |
47 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
27 |
26 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
76 |
53 |
$0.00 |
| J2560 |
Injection, phenobarbital sodium, up to 120 mg |
34 |
25 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
25 |
25 |
$0.00 |
| C1766 |
Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away |
13 |
13 |
$0.00 |
| C1732 |
Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping |
32 |
27 |
$0.00 |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
17 |
12 |
$0.00 |
| D1208 |
Topical application of fluoride, excluding varnish |
20 |
20 |
$0.00 |
| 81511 |
|
12 |
12 |
$0.00 |
| A4590 |
Special casting material (e.g., fiberglass) |
12 |
12 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
13 |
12 |
$0.00 |